Who Is Cali Extrax? A Brand File on the Name That Rides 'Extrax'

Cali Extrax is two stories at once: a misattribution to correct and an opacity to grade. The misattribution: virtually everyone, including sources that should know better, treats Cali Extrax as a Delta Extrax sister brand from Savage Enterprises. The filings say it isn't. The opacity: strip away the borrowed familiarity of the 'Extrax' name and you're left with a Wyoming-formed LLC that names no entity on its site, whose contact page is a dead link, whose manufacturing and sourcing are total blanks, and whose one disclosed strength, a named-lab COA library, tests potency and almost nothing else.

We'll credit what's real: PharmLabs San Diego is a genuine ISO-17025 lab, named right on the reports, and Cali Extrax is absent from the FDA's delta-8 warning sweeps. We'll also be surgical about what isn't its record: a Nebraska enforcement case it is not a party to, and a BBB grade that belongs to a different company.

Say 'Extrax' and the industry hears Savage Enterprises, the Orange County operation behind Delta Extrax. So it's no surprise that retailers, review sites, and AI summaries routinely describe Cali Extrax as a Savage brand. We assumed the same going in. The public record says otherwise.

One more precision cut, because it's where sloppy write-ups go wrong in the other direction: the Nebraska Attorney General's complaint against the Savage/Delta Extrax parties includes a state-testing allegation about a 'Cali Reserve'-branded gummy said to be mislabeled. Whatever that allegation is ultimately worth (it is an allegation in a pending case, not a finding), Cali Extrax is not a defendant in that action. We report the item because the product name invites confusion, and we attribute it exactly as the complaint does: to a case whose defendants are the Savage parties, not this company.

Correcting who doesn't own Cali Extrax still leaves the question of who does, and the answer is thin:

• The site names no one and nothing. No legal entity, no founders, no executives, no physical address. The brand's contact page returns a 404, a dead link where the company's front door should be. For a seller of intoxicating products, that's close to the floor of basic reachability.
• The filings give one name. California Secretary of State records list Zachary Flanagan as CEO/manager of Cali Extrax, LLC. That name appears nowhere on the brand's site, and we know nothing about him beyond the filing, so that's all we print.
• The addresses are mail drops. The managers in the filings are listed at Wyoming mail-forwarding addresses, the registered-agent style of address that exists to hold mail rather than house a company. Wyoming formation plus mail-drop managers is a lawful structure, and it is also a structure that discloses nothing.

Manufacturing and sourcing are total blanks. No facility, no GMP or ISO claim, no in-house-versus-white-label answer, no hemp source, no state of origin, nothing. Between the anonymous site and the mail-drop paperwork, a customer cannot establish where these products come from, who makes them, or who answers if something goes wrong. That's why three of our six pillars score in the single digits.

Here is the genuine credit in this file, and its sharpest limit:

• The COA library is real, and the lab is named. Cali Extrax maintains a per-product lab-results library, and the reports come from PharmLabs San Diego, a named ISO-17025-accredited laboratory. Naming an accredited lab is the single thing we most reward in testing, and Cali Extrax does it while far bigger brands don't.
• But the panels are potency-only. The reports we pulled measure cannabinoid content and stop. We could not confirm heavy-metal, residual-solvent, or pesticide screens on the products, including the vapes, where solvent and metal testing is precisely what a COA needs to rule out for an inhaled, converted-cannabinoid product.
• And then there's Scrip7. Cali Extrax sells 'Scrip7' tablets whose posted COA is a panel in which every listed analyte is reported as non-detect, while neither the COA nor the product listing discloses what the active ingredients actually are. Read that again: the lab report proves only what is not in the tablet, and the company never says what is. We make no claim about what Scrip7 contains, because no public document says. A flagship product whose own paperwork establishes only absence is, factually, the reddest flag in this file.

A named accredited lab earns real points here, and it's why this pillar is Cali Extrax's highest. Potency-only scope and an actives-undisclosed flagship are why it still lands below half marks.

Cali Extrax's record requires more precision than most, because its two most-cited negatives belong partly or wholly to another company:

• The March & Ash suit (theirs, and pending). Cali Extrax is a named defendant in the unfair-competition suit brought by licensed California cannabis operators (San Diego Superior Court, No. 37-2023-00041548, filed September 2023), which alleges that intoxicating hemp products compete unlawfully with the licensed market. The Delta Extrax/Savage parties are separate co-defendants in the same case. The suit is pending; every claim in it is an unadjudicated allegation, and being sued is not a finding of wrongdoing. We count the exposure, not a verdict that doesn't exist.
• The Nebraska case (not theirs). The Nebraska AG's suit targets the Savage/Delta Extrax parties. Its complaint mentions a 'Cali Reserve' gummy in a testing allegation, but Cali Extrax is not a defendant, and we do not attribute that case to it.
• The BBB 'F' (not theirs either). Cali Extrax has no BBB profile of its own. The Irvine 'F' rating that searches surface belongs to Delta Extrax, and attaching it to Cali Extrax would repeat the exact conflation this file exists to correct.
• The verified positive: Cali Extrax is not named in the FDA's delta-8 warning-letter sweeps, and we found no FDA or FTC action against it.

In our view, Cali Extrax is a brand that borrowed the industry's most recognizable suffix and disclosed almost nothing of its own. The public record corrects the one thing everyone thinks they know (it is not a Savage Enterprises company) and then runs out fast: a Wyoming-formed LLC, one name in the filings, mail-drop addresses, a 404 contact page, and no manufacturing or sourcing story at all. Its named ISO-17025 COA library is real and genuinely creditable, but potency-only panels and a flagship tablet whose lab report proves only absence leave the testing story half-told for products this potent. An F (38/100).

The forward-looking fact, stated as a mapping and not a prophecy: under the federal hemp provisions effective November 2026, which impose a total-THC standard and a per-container cap, Cali Extrax's catalog as currently written sits almost entirely outside the new definitions; high-potency converted-cannabinoid vapes and blends are the products the statute redefines out of the legal hemp channel. That is where today's product list falls against the law's text, nothing more. If you buy Cali Extrax anyway: pull the PharmLabs COA for your exact product, note what the panel does and doesn't cover, and treat any product whose actives aren't disclosed as a hard pass. The full methodology shows every point; if Cali Extrax names its entity and people on-site, fixes its contact page, discloses its manufacturing, and publishes full panels, we'll re-grade it (see the notice below).